These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24155157)

  • 21. A novel antibiotic bone assay by liquid chromatography/tandem mass spectrometry for quantitation of tigecycline in rat bone.
    Ji AJ; Saunders JP; Wadgaonkar ND; Petersen PJ; O'Leary K; McWilliams WE; Amorusi P; Leal M; Fluhler EN
    J Pharm Biomed Anal; 2007 Aug; 44(4):970-9. PubMed ID: 17537611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of an LC-MS/MS method for the determination of tigecycline in human plasma and cerebrospinal fluid and its application to a pharmacokinetic study.
    Mei S; Luo X; Li X; Li Q; Huo J; Yang L; Zhu L; Feng W; Zhou J; Shi G; Zhao Z
    Biomed Chromatogr; 2016 Dec; 30(12):1992-2002. PubMed ID: 27245381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative analysis and pharmacokinetics study of tigecycline in human serum using a validated sensitive liquid chromatography with tandem mass spectrometry method.
    Xie J; Wang T; Wang X; Cheng X; Dong H; Wang Y; Zheng X; Zhou L; Xing J; Dong Y
    J Sep Sci; 2014 Jun; 37(12):1396-403. PubMed ID: 24659422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Penetration, efflux and intracellular activity of tigecycline in human polymorphonuclear neutrophils (PMNs).
    Ong CT; Babalola CP; Nightingale CH; Nicolau DP
    J Antimicrob Chemother; 2005 Sep; 56(3):498-501. PubMed ID: 16024591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tigecycline pharmacokinetics, tolerability, safety, and effect on intestinal microflora in healthy Japanese male subjects.
    Yamashita N; Matschke K; Gandhi A; Korth-Bradley J
    J Clin Pharmacol; 2014 May; 54(5):513-9. PubMed ID: 24243316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid penetration of tigecycline.
    Pallotto C; Fiorio M; D'Avolio A; Sgrelli A; Baldelli F; Di Perri G; De Socio GV
    Scand J Infect Dis; 2014 Jan; 46(1):69-72. PubMed ID: 24131423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the anticoagulant ethylenediamine tetra-acetic acid (EDTA) on the estimation of pharmacokinetic parameters: A case study with tigecycline and ciprofloxacin.
    Chen Q; Tung EC; Ciccotto SL; Strauss JR; Ortiga R; Ramsay KA; Tang W
    Xenobiotica; 2008 Jan; 38(1):76-86. PubMed ID: 17963190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of linezolid and tigecycline as candidates for local prophylaxis via antibiotic-loaded bone cement.
    Nichol T; Smith TJ; Townsend R; Stockley I; Akid R
    J Antimicrob Chemother; 2017 Feb; 72(2):410-416. PubMed ID: 27798203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of tigecycline penetration into colon wall tissue and epithelial lining fluid using a population pharmacokinetic model and Monte Carlo simulation.
    Rubino CM; Ma L; Bhavnani SM; Korth-Bradley J; Speth J; Ellis-Grosse E; Rodvold KR; Ambrose PG; Drusano GL
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4085-9. PubMed ID: 17846139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
    Housman ST; Hagihara M; Nicolau DP; Kuti JL
    J Antimicrob Chemother; 2013 Oct; 68(10):2296-304. PubMed ID: 23710070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and safety profile of tigecycline in children aged 8 to 11 years with selected serious infections: a multicenter, open-label, ascending-dose study.
    Purdy J; Jouve S; Yan JL; Balter I; Dartois N; Cooper CA; Korth-Bradley J
    Clin Ther; 2012 Feb; 34(2):496-507.e1. PubMed ID: 22249106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exposure-response analyses of tigecycline tolerability in healthy subjects.
    Passarell J; Ludwig E; Liolios K; Meagher AK; Grasela TH; Babinchak T; Ellis-Grosse EJ
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):123-9. PubMed ID: 19748422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of feeding on the pharmacokinetics of oral minocycline in healthy research dogs.
    Hnot ML; Cole LK; Lorch G; Rajala-Schultz PJ; Papich MG
    Vet Dermatol; 2015 Dec; 26(6):399-405, e92-3. PubMed ID: 26283447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of tigecycline penetration into the epithelial lining fluid of infected and uninfected murine lungs.
    Crandon JL; Kim A; Nicolau DP
    J Antimicrob Chemother; 2009 Oct; 64(4):837-9. PubMed ID: 19696049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of tigecycline in human plasma by LC-MS/MS and its application to population pharmacokinetics study in Chinese patients with hospital-acquired pneumonia.
    Shao R; Li X; Hu Y; Chen J; Lou H; Dai H
    Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28677837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic/pharmacodynamic profile for tigecycline-a new glycylcycline antimicrobial agent.
    Meagher AK; Ambrose PG; Grasela TH; Ellis-Grosse EJ
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):165-71. PubMed ID: 16105560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of sucralfate on oral minocycline absorption in healthy dogs.
    KuKanich K; KuKanich B; Harris A; Heinrich E
    J Vet Pharmacol Ther; 2014 Oct; 37(5):451-6. PubMed ID: 24611544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics, pharmacodynamics, safety and tolerability of tigecycline.
    Rello J
    J Chemother; 2005 Aug; 17 Suppl 1():12-22. PubMed ID: 16285354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum and bone concentrations of teicoplanin and vancomycin: study in an animal model.
    Drago L; De Vecchi E; Fassina MC; Gismondo MR
    Drugs Exp Clin Res; 1998; 24(4):185-90. PubMed ID: 10051964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and distribution of minocycline in mature horses after oral administration of multiple doses and comparison with minimum inhibitory concentrations.
    Schnabel LV; Papich MG; Divers TJ; Altier C; Aprea MS; McCarrel TM; Fortier LA
    Equine Vet J; 2012 Jul; 44(4):453-8. PubMed ID: 21950341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.